[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.] [$clsd](/topic/$clsd) ### Sentiment: XX%  [Sentiment 24-Hour Chart Data](/topic/$clsd/time-series/sentiment.tsv) **Current Value**: XX% **Daily Average**: XX% **1 Month**: XX% +58% **1-Year High**: XXX% on 2025-06-01 **1-Year Low**: XX% on 2025-06-10 **Most Supportive Themes** - **Stock Recommendations:** (40%) Mentions of the stock in the context of stock trading gains and recommendations. - **Drug Approval:** (15%) Approval from Health Canada for XIPERE, a drug from Clearside Biomedical. **Most Critical Themes** - **Stock Loser:** (35%) Stock is down, with multiple posts mentioning it as a top loser. - **Downgrade:** (10%) Needham downgrades Clearside Biomedical to Hold from Buy. Network engagement breakdown: | Network | Positive | % | Neutral | % | Negative | % | | ------- | -------- | - | ------- | - | -------- | - | | X | XXXXX | XX% | XXXXXX | XX% | XXX | X% | | YouTube | X | X% | XX | X% | XX | X% | | | | | | | | | | Total | XXXXX | XX% | XXXXXX | XX% | XXX | X% |
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
Sentiment 24-Hour Chart Data
Current Value: XX%
Daily Average: XX%
1 Month: XX% +58%
1-Year High: XXX% on 2025-06-01
1-Year Low: XX% on 2025-06-10
Most Supportive Themes
Most Critical Themes
Network engagement breakdown:
Network | Positive | % | Neutral | % | Negative | % |
---|---|---|---|---|---|---|
X | XXXXX | XX% | XXXXXX | XX% | XXX | X% |
YouTube | X | X% | XX | X% | XX | X% |
Total | XXXXX | XX% | XXXXXX | XX% | XXX | X% |
/topic/$clsd/sentiment